<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">The hippo pathway is a signaling cascade that plays an evolutionarily conserved role in organ size control from Drosophila to humans by regulating cell proliferation, apoptosis, stem cell/progenitor cell fate determination, self-renewal control, and tissue architecture and renewal 
 <xref rid="bib36" ref-type="bibr">[36]</xref>, 
 <xref rid="bib37" ref-type="bibr">[37]</xref>, 
 <xref rid="bib38" ref-type="bibr">[38]</xref>. Mutations of these genes lead to a common phenotype of tissue overgrowth and enlarged organ size in Drosophila eyes and wings 
 <xref rid="bib39" ref-type="bibr">[39]</xref>. Hippo pathway components also mediated crosstalk with other pathways, for example, Wnt, TGF, and BMP pathways 
 <xref rid="bib40" ref-type="bibr">[40]</xref>. In the present study, the differentially expressed proteins, 1433Z and ACT6, of the hippo pathway were up-regulated in 
 <italic>D.Â melanogaster</italic> treated by RGE versus wild type. This may indicate a role in maintaining cellular health and tissue turnover, induced by RGE treatment.
</p>
